Key facts
- Predisurge’s last known valuation is $12.6M (Sep 2023).
- It has raised $9.1M; the latest was Later Stage VC ($350K) in Sep 2025.
- Notable investors include European Innovation Council, UI Investissement, LIFTT, Credit Agricole Lhl Capital Innovation, La Synapse — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Predisurge
- ·The full record, as it builds
Funding rounds
No funding rounds for Predisurge are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Predisurge
Developer of decision-making tools designed to offer secure cardiovascular interventions. The company's platform offers to design and implant cardiovascular medical devices and the creation of patient-specific digital twins, numerical models simulating arteries and valves, enabling physicians to care for patients more personalized and secure by providing the right data at each procedural stage, from preoperative planning to follow-up, based on our numerical simulation technology.
- Sector
- Healthcare
- HQ
- Saint-Étienne, France
- Founded
- 2017
- Employees
- 39
- Website
- predisurge.com/
- Ownership
- Privately Held (backing)
Predisurge doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Predisurge shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Predisurge in its N-PORT filings yet. We sweep new filings monthly.